Эффективность противовирусной терапии хронического HCV гепатита пегилированным интерфероном Na-2a у женщин репродуктивного возраста
Диссертация
Последние десятилетня ознаменованы ростом числа инфицированных и страдающих вирусными хроническими заболеваниями печени, особенно среди лиц молодого возраста, а также появлением ряда новых лекарственных препаратов, позволяющих проводить успешное этиопатогепетическое лечение некоторых форм поражений печени. Это ведет к увеличению числа беременных и рожениц среди женщин страдающих хроническими… Читать ещё >
Список литературы
- Апросина З.Г.- Аутоиммунный гепатит (история изучения, патогенез, роль вирусов, клинико-морфологическая характеристика, лечение) // Вирусные гепатиты. Достижения и перспективы, 1998,3 4 (4): 12−21.
- Безнощенко Г. Б., Сафонов А. Д., Ярков А. Н. Желтухи у беременных М: Медицинская книга, Н. Новгород:Изд-во НГМА, 2004 г.
- Буданов П. В. Баев О.Р. Диагностика и варианты комплексного лечения нарушений микроценоза влагалища. Вопросы гинекологии, акушерства и перннатологин 2002, 1(2) 73−77.
- Буданов П.В., Баев О. Р., Пашков В. М. Нарушения микроценоза влагалища. // Вопросы гинекологии, акушерства и перинатологин, 2005 том 4 № 2.
- Валленберг Х.С. С. Новые достижения в тактике ведения ранней преэклампсни и HELLP-снндрома//Акуш.и гинек.- 1998.-№ 5-с.29−33.
- Долгушина Н.В., Макацарня А. Д. Вирусные инфекции у беременных // Руководство для врачей «Триада —X», Москва, 2004.
- Игнатова Т.М. Хронические заболевания печени вирусной и невирусной этиологии у беременных: тактика ведения, лечения.// Вирусные гепатиты. Достижения и перспективы. -2000.-№ 1(14)-с.З-11.
- Кузьмин В. Н Вирусный гепатит С во время беременности. Лечащий врач. 1999,6,54−75.
- Кузьмина В.Н. Акушерская тактика у беременных с вирусным гепатитом В.// Вест.Росс.ассоц.акуш-гинек. -2001.- № 1- с.25−28.
- Ю.Лопаткнна Т.Н.- Опыт лечения хронического гепатита С высокими дозами интерферона альфа // Вирусные гепатиты. Достижения и перспективы, 1999,3(7): 16−19.
- Макацарня А.Д. Антифосфолипиднын синдром в акушерской практике. Научное нзданиею/ Под ред.А.Д. Макацарня- М: «Руссо» 2000,253−260.
- Макацарня Л. Д. Долгушина Н.В Герпетическая инфекция, антифосфолипиднын синдром и синдром потерн плода, изд."ТриадаХ", Москва, 2004.
- З.Никитин И. Г., Сторожаков Г. И. Пегилированные лекарственные препараты: современное состояние проблемы и перспективы. Вирусные гепатиты 2001- 3(13): 3−8.
- Никнтин И.Г. «Клиника, диагностика и этиопатогенетическое лечение хронического HCV-гспатита» Дисс. на соискание уч.ст.д.м.н. Москва, 2000
- Ннкитин И.Г., Кузнецов СЛ., Сторожаков Г. И. и др. -Хронический HCV-гепатит с нормальным уровнем аланиновой трансамнназы: интсрферонотерапия или активное наблюдение? // Клип, мед., 1998, 6: 41−44.
- Новикова С.В., Левашова И. И. Логутова Л.С. Выбор метода санации родовых путей накануне родоразрешения. Вестник российской ассоциации акушеров- гинекологов 1999 г, 1 :72−73.
- Селиванов Е. В. Иммунные нарушения и особенности лабораторной диагностики АФС. Дисс. на соиск. уч. ст. канд.мед. наук, Москва, 1998.
- Сорннсон С.Н. Вирусные гепатиты, 2-е изд. С.- П.: 1998.
- Соринсоп С.Н. Особенности патогенеза и течения гепатита С. Оптимальные сроки лечения интерфероном // Вирусные гепатиты. Достижения и перспективы. 1998, 1: 3−8.
- Соринсон С.Н., Корочкина О. В., Жданов Ю. Е. и др. Латентная фаза хронического гепатита С: критерии диагностики и терапевтическая практика // Вирусные гепатиты. Достижения и перспективы, 1999, 1(5): 17−21.
- Стрижаков А. Н. Давыдов А.И. Баев О. Р. Буданов П.В. Генитальные инфекции. М. ж Изд.дом «Династия» 2003.
- Турьянов М.Х., Федосеев М. А., Аленов М. Н. и др.- Новые подходы к потагенетической терапии вирусных гепатитов // Тез. докладов на V Российской Гастроэнтерологической неделе, 1999: 321.
- ACOG educational bulletin. Viral hepatitis in pregnancy. Number 248, July 1998 American College of Obstetricians and Gynecologists. Int J Gynaecol Obstet. 1998−63:195−202. MEDLINE.
- Alberti A., Chemello L., Noventa F., et al. Therapy of hepatitis C: retreatment with alpha interferon. Hepatology 1997- 26 (Suppl 1): 137S-142S.
- Alric L, Costedoat N, Piette JC, et al. Hepatitis С and pregnancy. Rev Med Interne 2002- 23(3): 283−291.
- Alter H. Epidemiology of hepatitis С in the west // Semcir. Liver Dis 1995−15: 1110−220.
- Alter MJ. Epidemiology of hepatitis C. Hepatology 1997−26:62S-5S.
- Asherson RA, Cervera R, Piette JC, Shoenfeld Y. The antiphospholipid syndrome: history, definition, classification, and differential diagnosis.
- Azzari C, Resti M, et al. Mother-to-infant transmission of HCV is reiated to maternal peripheral blood mononuclear cell infection. Blood 2000- 96:2045−2048
- Bailon P., Palleroni A., Schaffer C.A. et al. Rational design of a potent, long-lasting form of interferon: A 40KDa branched polyethylene glycol-conjugated interferon alpha-2a for the treatment of hepatitis C. Bioconjug Chem 2001- 12:195 202.
- Biancone L, Monache M, Ricchi G, Pallone F. Prevalence of hepatitis В and С virus infection in Crohn’s disease. Gut 1997- 41 (suppl, 3): A 177, P 485.
- Brass C.A. Efficacy of interferon monotherapy in the treatment of relapsers and non- responders with chronic hepatitis С infection. Clin Ther 1998- 20: 388 397.
- Briggs GG, Freeman RK, Yafle SJ, Drugs in Pregnancy and Lactation 5th edition, Baltimore, MD: Williams & Wilkins, 1998 p 716−720.
- Brouwer J., Nevens F., Kleter B. et al. Efficacy of interferon dose and prediction of response in chronic hepatitis C: Benelux study in 336 patients // J. Hepatol 1998- 28:951−959.
- Caldwell C., Lucey M. Muto ergo sum- hepatitis С and the forms of evolution//J Clin. Gastroenterol., 1996- 21: 1−13.
- Castlt SP, ct al. Chronic herpes gestations and APL antibody syndrome successfully treated with cyclophosphamide. J Am Acad Dermatol 1996- 34(2): 333−336
- Centers for Disease Control and Prevention. Recommendations for follow-up of health-care workers after occupational exposure to hepatitis С virus // MMWR CDC Surveill. Summ. 1997- 46: 603−6.
- Conte D, Fraquelli M, Prati D, Colucci A, Minola E. Prevalence and clinical course of chronic hepatitis С virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women.Hepatology. 2000−31:751−5. MEDLINE
- Craig J. R., Bain V.G., Ehrinpreis M. et al. Liver histology improves in both cirrhotic and non cirrhotic patients with chronic HCV infection following consensus interferon therapy//Gastroenterology 1997- 112: A — 1248.
- Davis G.L. Combination therapy with interferon alpha and ribavirin as retreatment of interferon relapse in chronic hepatitis C. Semin Liver Dis 1999- 19 (Suppl 1): 49−55.
- Dhumeaux D., DofToel M., Galmiche J. P. A French consensus conference on hepatitis C: screening and treatment // J. Hepatol., 1997- 27: 941- 944.
- Dienstag J.L. Sexual and perinatal transmission of hepatitis C. // Hepatology. -1997.-v.26(SuppI. 1)-p.66S-70S.
- Diepolder H., Zachoval R., Hoffman R. et al. Possible mechanism involving T-Iymphocytc responce to non-structural protein 3 in viral clearance in acute hepatitis С virus infection // Lancet, 1995- 346 (8981): 1006−1007.
- Dinsmoor MJ. Hepatitis С in pregnancy. Curr Womens Health Rep 2001- 1(1): 27−30.
- Dunn DT, ct al. Timing and interpolation of tests for diagnosing perinatally acquired HCV. Pediatr Oinfect Dis J 2001: 20: 715−716.
- EASL International Consensus Conference of Hepatitis C. J Hepatol 1999- 30 (Suppl 2): 956−961.
- EASL International Consensus Conference on Hepatitis C. Paris, 26−28, February 1999. Consensus Statement European Association for the Study of the Liver. J. Hepatol 1999- 30: 956−961.
- Emi K., Guh K., Nakamuru R. et al. Possibility of contribution to chronicity of HCV — infection of apoptosis in peripheral specific T-cells for HCV-related antigen//Gastroenterology 1997- 112, A — 1260.
- Esteban J. I., Genesca J., Alter II. J. Hepatitis C: Molecular Biology, Pathogenesis, Epidemiology, Clinical Features, and Prevention // Progresses in Liver Diseases 1992- 10: 253−282.
- Everson G.T. Liver problems in pregnancy: part 2 managing pre-existing and pregnancy-induced liver disease. // Medscape Womens I lelpth. — 1998. — v.3. p.2
- Everhart J. Management of hepatitis C: A national survey of gastroenterologists and hepatologists. National Consensus Development Conference on Management of Hepatitis C: Abstract 1997: 58−62.
- Ferenci P. — Evaluation of clinical efficacy IFNa + Ribavirine + Amantadine — therapy in patients with chronic hepatitis С // Am. J. Gastroenterology, 1999- 6(3): 1234−38
- Ferrero S, Lungaro P, Bruzzone BM, Gotta C, Bentivoglio G, Ragni N. Prospective study of mother-to-infant transmission of hepatitis С virus: a 10-year survey (1990−2000).ActaObstetGynecolScand. 2003−82:229−34.MEDLINE
- Ferri C., La Civita L., Longombardo G. et al. Mixed cryoglobulinemia: a cross-road between autoimmune and lymphoproliferative disorders // International conference on interferons. Venice (Italy) 1998- 33.
- Ferri С., Monti M., La Civita L. et al. Hepatitis С virus infection in non-Hodgkinin's B-cell lymphoma complicating mixed cryoglobulinemia // Eur. J. Clin. Invest. 1994- 24: 781−784
- Floreani A, Paternoster D, Zappala F, Cusinato R, Bombi G, Grclla P, Chiaramonte M. Hepatitis С virus infection in pregnancy. Br J Obstet Gynaecol. 1996−103:325−9. MEDLINE
- Formann E., Jessner W., Bennett L. et al. Twice weekly administration of peginterferon-a-2b improves viral kinetics in patients with chronic hepatitis С genotype 1. J Viral Hepat 2003−10(4):271−276.
- Foster G. R., Finter N.B. Are all type I human interferons equivalent // Journal of Viral Hepatitis, 1998- 5: 143−152.
- Foster G., Goldin R., Main J. The management of chronic hepatitis C: clinical audit of a biopsy based management algorithm // Br. Med. 1997- 315: 453−458.
- Foster GR. Effects of mode of delivery and infant feeding on the risk of mother-to-child transmission of HCV. BJOG 2003- 110(1):91.
- Fried M., Shiftman M., Reddy K. et al. Peginterferon alfa-2a plus ribavirin for chronic hepatitis С virus infection. N. Engl. J. Med., 2002,347, 975−982.
- Gibb DM, Goodall RL, Dunn DT, et al Mother-to-child transmission of hepatitis С virus: evidence for preventable peripartum transmission. Lancet. 2000 Sep 9−356(9233):904−7. MEDLINE
- Glue P., Fang J., Rouzier-Panis R. et al. Pegylated interferonalpha2b: pharmacokinetics, pharmacodynamics, safety and preliminary efficacy data. Clin. Pharmacol. Ther., 2000, 68, 556−567.
- Gordon S.C. Extrahepatic Manifestations of Hepatitis С // Dig. Dis., 1996- 14: 157−168.
- Granovsky MO, MinkoffHL, Tess BH, et al. Hepatitis С virus infection in the mothers and infants cohort study. Pediatrics 1998−102:355−9.
- Hadziyannis S. J.- The spectrum of extrahepatic manifestations in hepatitis С virus infection //J. of Viral Hepatitis, 1997- 7: 9−28.
- Hadziyannis S., Sette H., Morgan T. et al. Pegintcrferon- 2a and ribavirin combination therapy in chronic hepatitis C. A randomized study of treatment duration and ribavirin dose. Ann. Intern. Med., 2004, 140, 346−355.
- HeaIy CM, et al. Outcome of infants born to hepatitis С infected women. Ir J Med Sci 2001- 170:103−106.
- Hepatitis C: EASL Consensus (Paris Meeting) // J. Hepatology, 1999, vol. 4.: 234−268.
- Hiratsuka M, Minakami H, Koshizuka S, Sato I. Administration of interferon-alpha during pregnancy: effects on fetus. J Perinat Med. 2000−28:372−6. MEDLINE
- Hunt CM, Carson KL, Sharara Al. Hepatitis С in pregnancy.// Obstet Gynecol 1997 May, 89 (5 Pt 2) 883−90
- IIupertz VF, Wyllic R., Perinatal hepatitis С infection. Pediatr Inf Dis J 2003- 4(22).
- Jabeen T, Cannon B, et al. Pregnancy and pregnancy outcome in hepatitis С type lb.QJM. 2000 Sep-93(9):597−601. MEDLINE
- Jen J., Glue P., Ezzet F. et al Population pharmacokinetic analysis of pegylated interferon alfa-2b and interferon alfa-2b in patients with chronic hepatitis C. Clin. Pharmacol. Ther., 2001, 69, 407−421.
- Juki N., Hayashi N., Moribe T. et al. relation of disease activity during chronic hepatitis С infection to complexity of hypervariable region 1 quasispecies // Hepatology, 1997- 25 439−444.
- Kage M., Ogasawara S., Kosai K. et al. Hepatitis С virus RNA present in saliva but absent in breast milk of the hepatitis С carrier mother // J.Gastroenterol. Hepatol. 1997- 12:518−21.
- Kato N., Ikeda M., Sigiyama К et al. Hepatitis С virus population dynamics in human lymphocytes and hepatocytes infected in vitro // J. Gen. Virol., 1998, 79: 1859−1869.
- Kozlowski A., Charles S., Harris J. Development of pegylated interferons for the treatment of chronic hepatitis C. BioDrugs, 2001, 15,419−429.
- Krams S. M, Hayashi M., Fox CK et al. CD8+ cells are not necessary for allograft rejection or the induction of apoptosis in an experimental model of smoll intetestinal transplantation//J Immunol., 1998- 160: 3673−3680.
- Kudo Т., Yanase Y, Ohshiro M. et al. Analysis of mother-to-infant transmission of hepatitis С virus: quasispecies nature and buyant densities of maternal virus populations. //J.Med.Virol. 1997. -v.51.-p.225−230.
- Lamb M., Martin N. Weight based dosing vs. fixed dosing of peginterferon (40 kDa) alfa-2a. Ann. Pharmacother., 2002, 36, 933−935.
- Lindsay К., Trepo C., Heintges T. et al. A randomized, double- blind trial comparing pegylated interferon alfa-2b to interferon alfa-2b as initial treatment for chronic hepatitis C. Hepatology, 2001, 34,395−403.
- Lin H-H, Kao J-H, Hsu H-Y, et al. Absence of infection in breast-fed infants born to hepatitis С virus-infected mothers. J Pediatr 1995−126:589−91.
- Manns M., McHutchison J., Gordon S. et al. Pegintrferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C, a randomised trial. Lancet, 2001, 358, 958−965.
- Maertens G., Stuyver L. Genotypes and Genetic Variation of Hepatitis С virus: In the book: Molecular Medicine of Viral Hepatitis 1997- 183: 233.
- Manns M. P., Obermager-Straub P. Cytochromes P450 and uridine triphosphate-glucuronosyl-transferases: Model autoantigens to study drug-induced, virus-induced and autoimmune liver disease // Hepatology, 1997- 26: 1054−1066.
- Manns MP, Rambusch EG. Autoimmunity and extrahepatic manifestations in hepatitis С virus infection. J Hepatol 1999- 31(suppl 1): 39−42.
- Manzini P, Saracco G, Cherchier A, et al. Ilumanimmunodeficiency virus infection as risk factor for mother-to-child hepatitis С virus transmission- J Hepatol 1999- 40−43
- Marnik C. Hepatitis С in Focus of NIH Consensus panel. JAMA 1997- 277, 16: 1268−1269.
- McIIutchison J., Gordon S., SchifF E. et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N. Engl. J. Med., 1998, 339, 1485−1492.
- Memon M.I., Memon M.A. Hepatitis C: an epidemiological review. J Viral Hepat 2002−9:84−100.
- Michelsen P.P., Van Damme P. Viral hepatitis and pregnancy. // Acta Gastroentcrol.Belg.-1999.-v.62.-p.21 -29.
- Minola E., Persiani P., Amuso G. Clinical features of hepatitis С virus (HCV) infection in pregnancy// Int. J. Gynecol. Obstet. 1997- 58: 245−6.
- Moriya T, Sasaki F, Mizui M. Transmission of hepatitis С virus from mothers to infants: Its frequency and risk factors revisited. Biomed Pharmacother 1995−49:59−64.
- Mousulli J., Opolon P., Poynard T. Management of hepatitis С // J. Viral Hep., 1998- 5: 73−82.
- National Institutes of Health Consensus. Development Conference Panel Statement: management of hepatitis С // Hepatology 1997- 26 (suppl 1): 2−10.
- Nauclcr Cs. A novel mechanism for virus-induced autoimmunity in humans. Immunol Rev 1996- 152: 175−92lOO.Ozaslan E, Yilmaz R, Simsek H, Tatar G. Interferon therapy for acute hepatitis С during pregnancy. Ann Pharmacother. 2002−36:1715−8.MEDLINE
- Palomba E., Manzini P., Fiammengo P. et al. Natural history of perinatal hepatitis С infection // Clin. Infect. Dis. 1996- 23: 47−50.
- Panigrahi A., Panda S., Dixit R. et al. Magnitude of hepatitis С virus infection in India- prevalence in healthy blood donors, acute and chronic liver diseases//J. med. Virol. 1997- 51: 167−175.
- Paternoster DM, Santarossa C, Stella Л, et al. Pregnancy in women infected with hepatitis С virus. Acta Biomed Ateneo Parmense 2000- 71 (suppl l):553−557.
- Paternoster DM, Santarossa C, Grella P, Palu G, Baldo V, Boccagni P, Floreani A. Viral load in HCV RNA-positive pregnant women. Am J Gastroenterol. 2001−96:2751−4. MEDLINE
- Peginterfcron alfa-2b Product Information. Kenilworth, NJ, USA: Schering Corporation.
- Policy Statement. National Institutes of Health Consensus Development Panel Statement: management of hepatitis С // Hepatology, 1997- 26 (suppl.1): 25−105.
- Polwka S., Feucht H., Zoller B. et al. Hepatitis С infection in pregnancy and the risk of mother to child transmission // EurJ.Clin. Microbial Infect Dis. 1997- 16: 121−4.
- Polywka S, et al. Low risk of vertical transmission of HCV by breast milk. Clin Infect Dis 1999- 29: 1327−1329.
- Poynard Т., Bedossa P., Opolon P- Natural history of liver fibrosis progression in patients with chronic hepatitis С // Lancet, 1997- 349: 825−832.
- Poynard Т., Leroy K., Cohard M. et al. Meta-analysis of interferon randomised trials in the treatment of viral hepatitis C: effects of dose and duration// Hepatology. 1996- 24: 778−89.
- Reichard О., Norkrans G., Fryden Л. ct al. Randomised, double-blind, placebo- controlled trial of interferon a-2b with and without ribavirin for chronic hepatitis С // Lancet. 1998- 351: 83−7.
- Reddy K. R. Controlled-release, pegylated, liposomal formulations: new mechanisms in the delivery of injectable drugs. Ann Pharmacother 2000- 34:915 923.
- Reyes G.R. Ribavirin: recent insights into antiviral mechanisms of action. Curr Opin Drug Discov Devel. 2001 Sep-4(5):651−656.
- Riely C.A. Liver disease in pregnant patient. // AmJ.Gastroenterol. 1999. — v.94. — p.1728−1732.
- Robbins P. A., Maino V. C., Warner N.L.- Activated T- cells and monocytes have characteristic patterns of class II antigen expression // J. Immunol., 1998- Vol. 144, N4: 1281−1287.
- Salleras L., Bruguera M., Vidal J. et al. Importance of sexual transmission of hepatitis С virus in seropositive pregnant women: a case-control study // J. Med. Virol. 1997- 52: 164−7.
- Sanchez -Tapias J.M., Barrera J., Costa J. et al. Hepatitis С virus infection in patients with nonalcoholic chronic liver disease // Ann Intern Med., 1998- 112: 921−924.
- Sharara A .1., Hunt C.M., Hamilton J.D. Hepatitis С // Ann Intern. Med., 1998- 125: 658−668.
- Sherlock S., Dooley J. Diseases of the liver and biliary system 10-th ed. London Blackwell Science Ltd., 1997.
- Shimizu U.K., Igarashi H., Kancmatu T. et al.- Sequence analysis of the hepatitis С virus genome recovered from serum, liver and peripheral blood mononuclear cells of infected chimpanzees// J Virol. 1998- 71: 5769−5773.
- Simmonds P. Variality of hepatitis С virus // Hepatology, 1995- 21: 570 583.
- Targan S.R., Landers С., Vidrich A., Czaja A.J. High- titer antineutrophil cytoplasmic antibodies in type- 1 autoimmune hepatitis//Gastroenterology, 1995- 108: 1159−1166.
- Tajiri H, Miyoshi Y, Funada S, Etani Y, Abe J, Onodera T, Goto M, Funato M, Ida S, Noda C, Nakayama M, Okada S. Prospective study of mother-to-infant transmission of hepatitis С virus. Pediatr Infect Dis J. 2001- 20:10- 4. MEDLINE
- Thomas DL, Gruninger SE, Siew C, Joy ED, Quinn TC. Occupational risk of hepatitis С infections among general dentists and oral surgeons in North America. Am J Med 1996- 100: 41−5.
- Tomimatsu M., Ishigaro N., Taniai M. et al. Hepatitis С vims antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, hepatocellular- cholangiocarcinoma) in Japan // Cancer, 1998- 72: 683- 688.
- Tong M. J., El- Farra N. S., Reires A. R, — Clinical outcomes after transfusion- associated hepatitis С //N. Engl. J. Med., 1995- 332: 1463- 1466.
- Vento S. Eflect of pregnancy on chronic hepatitis C. Lancet 2001- 357 (9253): 389- 390.
- Weistal R. Sexual transmission of hepatitis С virus/ J Hepatol 1999−31(suppl): 92- 95
- WHO. Annual Report (Viral Diseases Part): Epidemiological Situation on Hepatitis С- 1998- 1627- 31.
- Williams AE, Thomson RA, Schreibcr GB, et al. Estimates of infectious disease risk factors in US blood donors. JAMA 1997- 277: 967- 72.
- Wilson S. E., Lee W.M., Murakami C. et al. Mooren- type hepatitis С virus-associated corneal ulceration // Ophthalmology 1996- 101: 736- 745.
- World Health Organization. Eekly Epidemiologikal Record 49. 1999. W
- Zeuzem S., Feinman S., Rasenack J. et al. Peginterferon alfa-2a in patients with chronic hepatitis C. N. Engl. J. Med., 2000,343, 1666- 1672.
- Zignedo A .L., Ferri C., Giannini C. et al.- HCV interferon in B-cell non-Hodgkin's lymphoma//J. Hepatol., 1998- 23(Suppll): 77
- Zola H.- T-cells memory is a role for the MHC class II molecules on the T-cell? //Immunol. Cell Biol., 1992- Vol. 70: 337- 341.
- Zusima A. H., Fujsava H., Hirocata D. et al — Metalloprotease and growth factors in the extracellular matrix in patients with chronic hepatitis // The FASEB Journal, 1998- vol. 11: 51 59.
- Zykfenbach P.- Thyroid autoimmunity: natural history, occure, hystological variants and treatment// Acta Endocrin. Scand., 1999- 4(2): 1152